The Minister, Alexandru Rafila, was accompanied by the Director of Cabinet of the Romanian Ministry of Health and the...
06 Feb, 2023
The LAI Challenge seeks innovative solutions in the field of sustained-release injectable drug delivery technologies...
24 Nov, 2022
ROVI updates its strategy in a meeting with shareholders, investors and analysts
23 Nov, 2022
ROVI reports operating revenue growth of 24% and EBITDA growth of 25%
04 Nov, 2022
This new facility will double the production capacity of low molecular weight heparins.
24 Oct, 2022
ROVI, Càrniques Celrà and Grupo Costa announce the construction of a facility at the Industrial Logistics Platform in...
04 Oct, 2022
ROVI has obtained the best ESG score from among the 458 companies evaluated in its pharmaceutical subindustry category.
01 Aug, 2022
ROVI reports operating revenue growth of 31% and net profit growth of 58%
27 Jul, 2022
EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
19 Jul, 2022